CMN Weekly (20 December 2024) - Your Weekly CRISPR...
CMN Weekly
Dec. 20, 2024
Relevant Interviews, Webinar and Trial Updates posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
GEG-Tech
Company:
GEG-Tech
Main Focus:
Nanoparticles to delivery genome editors such as Zinc Finger Nuclease, CRISPR/Cas9 system, Prime Editing system or Base Editing system
Company Stage:
Research, Pre-clinical
Technology | Tool:
RNA-One is an unique nanoparticle that provides an exceptionally high level of biosafety without compromising its effectiveness and while embarking large payloads with a potential precision targeting function
Funding Stage:
Part of AdVenture Studio
Location:
Paris, France
Website:
https://www.geg-tech.com/
Contact Name:
Pascale BERTHET
Contact Email:
pascale.berthet@geg-tech.com
GEG Tech has been founded in 2013 in Paris, France. Our R&D team originated from cutting-edge research laboratories, notably the CNRS (the leading French research institution), and the Riken Institute (Japan), cumulating more than 15 years experience in pionneering research on genetic engineering. GEG Tech has designed nanoparticles with a high cargo capacity, combining biosafety and efficacy to deliver genome editing systems. These nanoparticles allow transient expression of genome editing systems, they are very stable due to their biologic components protecting the payload, and the mechanism of cell entry highly efficient.
Downloads
RNA-ONE_TECHNOLOGY-_THE_BEST_CARGO_FOR_in_Vivo_GENE_EDITING_STRATEGIES.pdfRNA-ONE TECHNOLOGY: THE BEST CARGO FOR in Vivo GENE EDITING STRATEGIES
